A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss. - Schilder AGM; Wolpert S; Saeed S; Middelink LM; Edge ASB; Blackshaw H; Pastiadis K; Bibas AG (Nature communications, 2024)